NEWTON, Mass.--(BUSINESS WIRE)--Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Harry S. Palmin, President and CEO of Novelos, will present at the Roth Capital Partners 20th Annual OC Conference on Tuesday, February 19, 2008. Mr. Palmin is scheduled to present at 8:30am PST (11:30am EST) at the Promenade. The event will be held at the Ritz Carlton, Laguna Niguel, CA.
